Research
Biomarkers and AI: New Ways to Understand Neurological Disorders
The Scientist · By Laura Tran & PhD ·
The Brief
- Researchers presented new insights into biomarkers and AI tools for Alzheimer's disease, depression, and other brain disorders.
- The work was presented at the 2026 Society for Neuroscience meeting.
- The source is a short news summary, so it does not give detailed study results or sample sizes.
Why it matters
Biomarkers and AI tools could change how neurological and psychiatric conditions are detected and studied, which matters for anyone building or evaluating diagnostic methods.
Who’s affected
- neuroscientists and clinicians working on neurological disorders
- researchers applying AI to brain health
Researchers presented new insights into biomarkers and AI tools for Alzheimer’s disease, depression, and other brain disorders at the 2026 Society for Neuroscience meeting.